INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,431,000 | -26.3% | 375,399 | +3.5% | 0.07% | -1.4% |
| Q1 2022 | $26,361,000 | -76.5% | 362,750 | -61.7% | 0.07% | -72.5% |
| Q4 2021 | $111,954,000 | -20.6% | 946,834 | -9.9% | 0.26% | -24.3% |
| Q3 2021 | $140,965,000 | -2.3% | 1,050,799 | +17.9% | 0.34% | -3.2% |
| Q2 2021 | $144,245,000 | +164.7% | 890,900 | +31.2% | 0.35% | +150.4% |
| Q1 2021 | $54,504,000 | +1438.4% | 679,141 | +155.9% | 0.14% | +1058.3% |
| Q3 2019 | $3,543,000 | -23.6% | 265,382 | -6.3% | 0.01% | -20.0% |
| Q2 2019 | $4,638,000 | -24.4% | 283,286 | -21.1% | 0.02% | -25.0% |
| Q1 2019 | $6,133,000 | +79.5% | 359,028 | +43.5% | 0.02% | +66.7% |
| Q4 2018 | $3,416,000 | -27.7% | 250,203 | +51.6% | 0.01% | -7.7% |
| Q3 2018 | $4,725,000 | – | 165,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |